约附近100元4小时电话或微信_大学生空降平台,24小时全国空降可约,全国楼凤约平台

Time

Program

Chairs

09:00—9:15

Opening Ceremony

1.      Welcome address by Yongxiang Zhang, CNPHARS President

2.      Opening speech bySatomiAkahane, JPS President

3.      Opening speech by delegate from JSCPT

4.      Opening speech by Fumiyoshi Yamashita, JSSX President

Chaoyu Miao

Young Scientist Presentation

09:15—09:30

Junichi Kikuta, Osaka University, Japan

Intravital imaging of in vivo pharmacological actions of drugs on the immune system

TomoyokiFuruyashiki

Yong Zhang

09:30—09:45

Xiao Li, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, China

Spermine Is a Natural Suppressor of AR Signaling in Castration-Resistant Prostate Cancer

09:45—10:00

Kazuhiro Nishiyama,Osaka Metropolitan University, Japan

Drug discovery research targeting functional modification of G protein-coupled receptors

10:00—10:15

Sili Zheng, Naval Medical University, China

Endothelial METRNL determines circulating METRNL level and maintains endothelial function against atherosclerosis

10:15—10:30

Group photoandTea break

10:30—10:45

Hirofumi Hamano, Okayama University Hospital, Japan

Investigating the Preventive Potential of Pre-existing Pharmacological Drug Against Cisplatin-Induced Nephrotoxicity

Norio Furukori

Fang Wang

10:45—11:00

Qingfeng He,Fudan University, China

Insights into Drug-Drug Interactions of Henagliflozin through Physiologically-based Pharmacokinetic Modeling

11:00—11:15

Toshinori Hirai,Mie University Hospital, Japan

Dose optimization of digoxin in patients with heart failure and atrial fibrillation

11:15—11:30

Guangyan Mu,Peking University First Hospital, China

Identification of genetic biomarkers associated with pharmacokinetics and pharmacodynamics of apixaban in Chinese healthy volunteers

11:30—14:00

Lunch&Poster presentations

Symposium 1

Pharmacology towards new therapeutics: lessons from biological systems
and natural products

14:00—14:30

Feng Han,Nanjing Medical University, China

Research progress on the pharmacological mechanism of natural products in brain diseases

Hitoshi Hashimoto

JianpingZuo

14:30—15:00

Rieko Muramatsu, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan

Systemic environments regulate central nervous system regeneration

15:00—15:30

Junke Song,Institute of Materia Medica, Chinese Academy of Medical Sciences, China

A study of the effects of baicalein in the treatment of COVID-19

15:30—16:00

Takahiro Masuda, Kyushu University, Japan

Novel insights into the ontogeny and diversity of CNS macrophages

Symposium 2

New developments in clinical pharmacology for overcoming diverse diseases

16:00—16:30

Wei Zhao,Shandong University, China

Model-Informed Drug Development: Innovative Approach in Early Phase Clinical Trials

Yuji Kumagai

Zhaoqian Liu

16:30—17:00

JunjiSaruwatari, Kumamoto University, Japan

Clinical Pharmacology Research for Precision Medicine in Epilepsy

17:00—17:30

Xiaocong Pang,Peking University First Hospital, China

Mechanisms of SPP1/αvβ3 axis mediated enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategy

17:30—18:00

Reo Tanoshima, Yokohama City University Hospital, Japan

Unique Aspects of Pediatric Clinical Pharmacology

Symposium 3

DMPK research facilitating treatment of diseases: new insights, new techniques

13:30—13:40

Speech by the CSSX President, Dr. Chuan Li

Speech by the JSSX President, Dr. Fumiyoshi Yamashita

Ling Yang

13:40—14:05

Koji Chiba, Yokohama University of Pharmacy, Japan

Exploratory use of physiologically based pharmacokinetic models -Possibility of novel drug transportation mechanism

Ling Yang

14:05—14:30

Chuan Li, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China

Pharmacokinetic-based research on pharmacologically active compounds of XueBiJing, a Chinese herbal medicine for sepsis care

KouichiYoshinari

14:30—14:55

TomomiFurihata, Tokyo University of Pharmacy and Life Sciences, Japan

Development and characterization of microphysiological system-based human blood-brain barrier models as key tools for central nervous system drug development

Su Zeng

14:55—15:20

Yan Wang, Institute of Materia Medica, Chinese Academy of Medical Sciences, China

Berberine treats atherosclerosis via down-regulating Choline-TMA-TMAO production pathway in the gut microbiota

Fumiyoshi Yamashita

15:20—15:30

ChenchunZhong,SCIEX Company

Bringing it to the next level: metabolite identification on the ZenoTOF 7600 system

Su Zeng

15:30—15:40

Break

15:40—16:05

Hidenori Ando, Tokushima University, Japan

Therapeutic outcome of combination treatment with PEGylated liposomal oxaliplatin and rituximab in B-cell lymphoma-xenograft mouse model

Guangbo Ge

16:05—16:30

JingkaiGu, Jilin University, China

The biological fate of PEGylated liposomal doxorubicin nanoparticles

Fumiyoshi Yamashita

16:30—16:55

MasashiHonma, The University of Tokyo Hospital, Japan

Machine learning approach to predict cancer cell sensitivity to anti-cancer agents

Guorong Fan

16:55—17:20

Huichang Bi, Southern Medical University, China

Novel role of xenobiotic nuclear receptors in liver injury and regeneration

KouichiYoshinari

17:20—17:30

Concluding talk

Hailing Qiao

18:00—18:20

Closing Ceremony

18:30—20:00

Dinner